Literature DB >> 10791384

Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C.

M Mikami, S Ezawa, N Sakaiya, Y Komuro, C Tei, T Fukuchi, M Mukai.   

Abstract

Among patients with uterine cervical cancer, glassy-cell carcinoma is very rare. The disease occurs mainly in younger patients, is rapidly progressive, and has a poor prognosis. We describe a case of glassy-cell carcinoma of the uterine cervix, in which preoperative intra-arterial chemotherapy was surprisingly effective.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10791384     DOI： 10.1016/S0140-6736(00)02070-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  4 in total

1.  Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy.

Authors:  Tomonori Nagai; Takashi Okubo; Riko Sakaguchi; Hiroyuki Seki; Satoru Takeda
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

2.  A case of primary metastatic glassy cell carcinoma of the uterine cervix that responded to combined docetaxel and carboplatin.

Authors:  Yuji Ukita; Hiroshi Tsubamoto; Toru Kato; Shigeo Suno; Hiroaki Shibahara
Journal:  Gynecol Oncol Case Rep       Date:  2013-07-22

Review 3.  [Glassy cell carcinoma of the cervix: report of a case and literature review].

Authors:  Ihssane Hakimi; Abdelghani Zazi; Hafsa Chahdi; Khalid Guelzim; Jaouad Kouach; Myabdellah Babahabib; Myehdi Elhassani; Driss Moussaoui Rahali; Mohammed Dehayni
Journal:  Pan Afr Med J       Date:  2015-09-18

4.  Glassy cell carcinoma of cervix: an analysis for 20 cases and literatures review.

Authors:  Qingxuan Wang; Yuanjing Hu; Ya He; Tian Wang; Pratima Ghimire
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.